Market Place
Sourcing Support
Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution
03 Jul 2023 //
GLOBENEWSWIRE
Long Grove Secures Commercial Rights to an Essential Critical Care Medication
04 May 2023 //
PR NEWSWIRE
Nevakar Injectables Sells 6 Development-Stage, Ready-to-Use Injectable Products
02 May 2022 //
GLOBENEWSWIRE
Endo Acquires Six Development-Stage, Ready-to-Use Injectable From Nevakar
02 May 2022 //
PRNEWSWIRE
Nevakar Nabs U.S. FDA Approval of Ready-to-Use Ephedrine Injection
28 Apr 2022 //
GLOBENEWSWIRE
Nevakar Injectables Announces Launch of Ready-to-Use Ephedrine Injection Vials
28 Mar 2022 //
GLOBENEWSWIRE
Nevakar says Closing of $12M Convertible Note
09 Mar 2022 //
GLOBENEWSWIRE
Nevakar Announces Formation Of Ophthalmic Company, Vyluma
25 May 2021 //
PRNEWSWIRE
Nevakar & Théa Enter into Licensing Agreement for Commercialization NVK-002
28 Jan 2021 //
GLOBENEWSWIRE
NEVAKAR ANNOUNCES FDA APPROVAL FOR EPHEDRINE SULFATE INJECTION
23 Oct 2020 //
PRESS RELEASE
Nevakar and Zhaoke Ophthalmology Enter into Licensing Agreement for NVK-002
20 Oct 2020 //
BIOSPACE
Nevakar and Zhaoke Ophthalmology Enter into Licensing Agreement for NVK-002
20 Oct 2020 //
BUSINESSWIRE
Themis Medicare inks pact with Nevakar for injectable products
15 Sep 2016 //
ECONOMIC TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.